These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32347951)

  • 21. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
    Casey MJ; Bewtra C; Lynch HT; Snyder C; Stacy M; Watson P
    Fam Cancer; 2013 Dec; 12(4):719-40. PubMed ID: 23666231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome.
    Biller LH; Horiguchi M; Uno H; Ukaegbu C; Syngal S; Yurgelun MB
    Gastroenterology; 2021 Jul; 161(1):143-150.e4. PubMed ID: 33794268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
    Manickam K; Buchanan AH; Schwartz MLB; Hallquist MLG; Williams JL; Rahm AK; Rocha H; Savatt JM; Evans AE; Butry LM; Lazzeri AL; Lindbuchler DM; Flansburg CN; Leeming R; Vogel VG; Lebo MS; Mason-Suares HM; Hoskinson DC; Abul-Husn NS; Dewey FE; Overton JD; Reid JG; Baras A; Willard HF; McCormick CZ; Krishnamurthy SB; Hartzel DN; Kost KA; Lavage DR; Sturm AC; Frisbie LR; Person TN; Metpally RP; Giovanni MA; Lowry LE; Leader JB; Ritchie MD; Carey DJ; Justice AE; Kirchner HL; Faucett WA; Williams MS; Ledbetter DH; Murray MF
    JAMA Netw Open; 2018 Sep; 1(5):e182140. PubMed ID: 30646163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
    Beebe-Dimmer JL; Kapron AL; Fraser AM; Smith KR; Cooney KA
    J Clin Oncol; 2020 Jun; 38(16):1807-1813. PubMed ID: 32208047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients.
    Côrtes L; Basso TR; Villacis RAR; Souza JDS; Jørgensen MMA; Achatz MI; Rogatto SR
    Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome.
    Agarwal R; Liebe S; Turski ML; Vidwans SJ; Janku F; Garrido-Laguna I; Munoz J; Schwab R; Rodon J; Kurzrock R; Subbiah V;
    Discov Med; 2014 Dec; 18(101):331-9. PubMed ID: 25549704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study.
    Adam F; Fluri M; Scherz A; Rabaglio M
    BMC Med Genomics; 2023 Jan; 16(1):7. PubMed ID: 36647026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry.
    Goldberg M; Bell K; Aronson M; Semotiuk K; Pond G; Gallinger S; Zbuk K
    J Med Genet; 2017 Nov; 54(11):742-746. PubMed ID: 28779004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
    Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
    Lahiri S; Pirzadeh-Miller S; Moriarty K; Kubiliun N
    Cancer Control; 2023; 30():10732748231175011. PubMed ID: 37161761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
    Heo Y; Kim MH; Kim DW; Lee SA; Bang S; Kim MJ; Oh HK; Kang SB; Kang SI; Park JW; Ryoo SB; Jeong SY; Park KJ
    Dis Colon Rectum; 2020 Feb; 63(2):152-159. PubMed ID: 31842160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.
    Singh AK; Talseth-Palmer B; Xavier A; Scott RJ; Drabløs F; Sjursen W
    BMC Med Genomics; 2023 Jun; 16(1):126. PubMed ID: 37296477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].
    Ohneda K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):231-236. PubMed ID: 38494798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
    Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
    Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.
    Jóri B; Kamps R; Xanthoulea S; Delvoux B; Blok MJ; Van de Vijver KK; de Koning B; Oei FT; Tops CM; Speel EJ; Kruitwagen RF; Gomez-Garcia EB; Romano A
    Oncotarget; 2015 Dec; 6(38):41108-22. PubMed ID: 26517685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
    Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
    Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically engineered mouse models for hereditary cancer syndromes.
    Biswas K; Mohammed A; Sharan SK; Shoemaker RH
    Cancer Sci; 2023 May; 114(5):1800-1815. PubMed ID: 36715493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.